Faculty profile

Srinivas Murthy

ResearcherUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses may be missing. Find their university profile.

Srinivas Murthy

Researcher

Health Sciences

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
114 publications in the last five years, latest in 2026.
Senior (last) author on 12 recent papers, a sign of leading a research group.
Principal investigator on 7 research grants (7 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

220

Publications

8,877

Citations

h-index

314

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Randomized Clinical Trial Clinical Characterization Knowledge Translation Stakeholder Perspectives Community Acquired Pneumonia Critical Care Antimicrobial Resistance Global Health

Latest papers

Greening critical care by harnessing the planetary impact of medications: What fellows need to know.
Journal of critical care · 2026 · senior author
Residual Myths in Feeding Critically Ill Children.
JAMA · 2026 · senior author
Enteral nutrition usage in critically ill children: A descriptive cohort study.
JPEN. Journal of parenteral and enteral nutrition · 2026

All 220 publications

Latest funding

Randomized Embedded Multifactorial Adaptive Platform Trial of Community Acquired Pneumonia
CIHR · 2022 · Nominated PI
$2,588,010
Randomized Embedded Multifactorial Adaptive Platform Trial of Community Acquired Pneumonia
CIHR · 2022 · Nominated PI
$647,004
CATCO Scale-Up COVID-19 Supplement - Canadian Treatments for COVID-19: SOLIDARITY
CIHR · 2021 · Nominated PI
$3,500,000

All 12 grants and awards

From the 150 most recent of 220 publications.

Greening critical care by harnessing the planetary impact of medications: What fellows need to know.

Uhland C, Mousa A, Montgomery H, Hunfeld N, Huckleberry Y, Nadkarni V, van Gelder P, Smale LM, Murthy S

Journal of critical care2026Senior author

DOI: 10.1016/j.jcrc.2026.155672 PMID: 42385527

Residual Myths in Feeding Critically Ill Children.

Berris K, Murthy S

JAMA2026Senior author

DOI: 10.1001/jama.2026.10505 PMID: 42283222

Enteral nutrition usage in critically ill children: A descriptive cohort study.

Berris K, Murthy S, Zhang Q, Jassal T, Ying J, Elango R

JPEN. Journal of parenteral and enteral nutrition2026

DOI: 10.1002/jpen.70142 PMID: 42687331

The challenge of recruitment in clinical trials in Canada: an analysis of trial registry data.

Tam ACT, Smith J, Harrison MJ, Murthy S, Bansback N

Journal of clinical epidemiology2026

DOI: 10.1016/j.jclinepi.2026.112334 PMID: 42142602

Timing, Translation, and Preparedness: Lessons Learned From COVID-19 Anticoagulation in Noncritically Ill Hospitalized Patients.

Tritschler T, Fuster V, Lawler PR, Farkouh ME, Marx CE, Neal MD, Sholzberg M, Spyropoulos AC, Tong SYC, Muñoz-Rivas N, Blondon M, Berger JS, Bikdeli B, Cattaneo M, Cushman M, Goldin M, Goligher EC, Hochman JS, Jüni P, McQuilten ZK, Morici N, Sadeghipour P, Venkatesh B, Zuily S, Amstutz A, Aujesky D, Carrier M, Hofstetter RV, Murthy S, Rodger M, Skeith L, Veroniki AA, Hutton B, Zarychanski R, Stone GW, Le Gal G, Anticoagulation in COVID-19 Investigators

Journal of the American College of Cardiology2026

DOI: 10.1016/j.jacc.2026.05.028 PMID: 42523015

Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP).

Hashmi M, Haniffa R, Jayakumar D, Beane A, Lorenzi E, Berry LR, Nasir Khoso M, Ain Khan Q, Kumar A, Altaf Kidwai A, Hills TE, Annane D, Aryal D, Au C, Baillie K, Beasley R, Best-Lane J, Bonten M, Bradbury CA, Brunkhorst FM, Burrell A, Buxton M, Cecconi M, Cheng AC, Cove ME, de Jong M, Detry MA, Duffy E, Estcourt LJ, Fitzgerald M, Fowler R, Goossens H, Green C, Hays LMC, Higgins AM, Huang DT, Ichihara N, Koirala S, Lamontagne F, Lawler PR, Lewis RJ, Litton E, Mahon N, Marshall JC, McAuley DF, McGlothlin A, McGuinness S, McQuilten ZK, McVerry BJ, Mouncey PR, Morpeth S, Netea M, Orr K, Parke RL, Parker JC, Patanwala A, Peters S, Reyes LF, Rowan KM, Saito H, Saunders CT, Santos M, Seymour CW, Shankar-Hari M, Singh V, Slater M, Tambyah PA, Tong SYC, Turgeon AF, Turner AM, van de Veerdonk F, Weis S, Zarychanski R, McArthur CJ, Angus DC, Berry SM, Gordon AC, Derde LPG, Webb SA, Murthy S, Arabi Y, Nichol AD, and the Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP) Investigators

Critical care medicine2026

DOI: 10.1097/ccm.0000000000007134 PMID: 42101205

Which issues should be addressed in future trials regarding the use of corticosteroids in community acquired pneumonia? A survey of REMAP-CAP investigators.

Heming N, Rudd KE, Murthy S, Angus DC, Teja B, REMAP-CAP Corticosteroid Domain-Specific Working Group

Intensive care medicine2026

DOI: 10.1007/s00134-026-08445-y PMID: 42047792

Intermediate dose heparin thromboprophylaxis among critically ill patients with COVID-19: a randomized clinical trial.

Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia (REMAP-CAP) Investigators, Bradbury CA, McVerry BJ, Lawler PR, Angus DC, Annane D, Arabi YM, Aryal D, Au C, Beane A, Berry SM, Berry LR, Best-Lane J, Bihari S, Bonten M, Brunkhorst F, Burrell A, Buxton M, Carrier M, Cecconi M, Cheng AC, Cove M, Derde LPG, Detry MA, Estcourt LJ, Fergusson DA, Fitzgerald M, Fowler RA, Goligher EC, Green C, Haniffa R, Harrison DA, Hays LMC, Higgins AM, Hills T, Horvat CM, Huang DT, Hunt BJ, Ichihara N, Jayakumar D, Keattch S, Kumar A, Laffan MA, Lamontagne F, Leeper CM, Lewis RJ, Lorenzi E, Lother SA, Marshall JC, McArthur CJ, McAuley DF, McGlothlin A, McGuinness SP, McQuilten ZK, Middeldorp S, Morpeth S, Mouncey PR, Murthy S, Neal MD, Nichol AD, Parke RL, Parker JC, Peters S, Reyes LF, Rowan K, Saito H, Santos M, Saunders CT, Schutgens REG, Seymour CW, Hari MS, Singh V, Stanworth SJ, Turgeon AF, Turner AM, van de Veerdonk FL, Gordon AC, Webb SA, Zarychanski R

Journal of thrombosis and haemostasis : JTH2026

DOI: 10.1016/j.jtha.2026.03.006 PMID: 41895526

Lessons learned and recommendations from the Canadian adaptive platform trial of treatments for COVID in community settings (CanTreatCOVID).

Hosseini B, Condon A, da Costa BR, Daley P, Greiver M, Jüni P, Lee TC, McBrien K, McDonald EG, Murthy S, Selby P, Pinto AD

Contemporary clinical trials2026

DOI: 10.1016/j.cct.2026.108303 PMID: 41985658

Time to extracorporeal cardiopulmonary resuscitation flow and outcomes in paediatric in-hospital cardiac arrest: a 12-year single-centre study.

Nyandat J, McClelland R, Mintak R, Murthy S, Edwards L

Resuscitation plus2026

DOI: 10.1016/j.resplu.2026.101326 PMID: 42064540

Randomized Embedded Multifactorial Adaptive Platform Trial of Community Acquired Pneumonia

Nominated PICIHR2022Operating Grant: Clinical Trials Projects-Canadian sites of international trials

Principal investigators: Murthy, Srinivas; Dalziel, Sandra; Kho, Michelle E; Marshall, John C; Park, Jay; Smith, Kathleen F

Keywords: Community Acquired Pneumonia; Critical Care; Randomized Clinical Trial

$2,588,010

Randomized Embedded Multifactorial Adaptive Platform Trial of Community Acquired Pneumonia

Nominated PICIHR2022Operating Grant: Clinical Trials Projects - Indirect Costs

Principal investigators: Murthy, Srinivas; Dalziel, Sandra; Kho, Michelle E; Marshall, John C; Park, Jay; Smith, Kathleen F

Keywords: Community Acquired Pneumonia; Critical Care; Randomized Clinical Trial

$647,004

CATCO Scale-Up COVID-19 Supplement - Canadian Treatments for COVID-19: SOLIDARITY

Nominated PICIHR2021Operating Grant: CATCO Scale-Up COVID-19 Supplement Funding Opportunity

Principal investigators: Murthy, Srinivas; Fowler, Robert A

Keywords: Clinical Characterization; Knowledge Translation; Randomized Clinical Trial; Stakeholder Perspectives

$3,500,000

Beyond Vaccine Nationalism: Advancing ethically-coherent policy action for equitable responses to inherently global health crises

Co-investigatorCIHR2021Op. Gr.:Emerg. COVID-19 Res. Gaps & Priorities - Healthcare Resource Allocation

Principal investigators: Plamondon, Katrina M

Keywords: Capacity Building; Deliberative Dialogue; Equity; Ethics; Global Governance; Global Health Issues; Pandemic; Policy Analysis; Political Economy; Vaccine Nationalism

$471,146

COVID-19 And Severe Community-Acquired Pneumonia Dynamic Evaluation Study (CASCADES - ARBS CORONA III)

Co-investigatorCIHR2021O. Gr.: Addr. the Health Impacts of COVID-19 - Imp. of def/disp care on health

Principal investigators: Russell, James A

Keywords: Bacterial Community-Acquired Pneumonia; Chronic Kidney Disease; Chronic Obstructive Pulmonary Disease; Covid-19; Individuals Experiencing Homelessness; Ras Pathway; Sepsis

$500,000

COVID-19 Variant Supplement - Canadian Treatments for COVID-19: SOLIDARITY

Nominated PICIHR2021Operating Grant: SARS-CoV-2 variants supplement stream 1

Principal investigators: Murthy, Srinivas; Fowler, Robert A

Keywords: Clinical Characterization; Knowledge Translation; Randomized Clinical Trial; Stakeholder Perspectives

$50,000

HOST RESPONSE MEDIATORS IN CORONAVIRUS (COVID-19) INFECTION - IS THERE A PROTECTIVE EFFECT OF ARBs ON OUTCOMES OF CORONAVIRUS INFECTION? (ARBs CORONA II)

Co-investigatorCIHR2020Operating Grant: COVID-19 Rapid Research Funding Opportunity - Therapeutics

Principal investigators: Russell, James A

Keywords: Arbs; Biomarkers; Covid-19; Host Response; Losartan; Randomized Controlled Trial

$3,456,541

Host Response Mediators in Coronavirus (COVID-19) Infection

Co-investigatorCIHR2020Operating Grant: COVID-19 - Clinical management

Principal investigators: Russell, James A

Keywords: Arbs; Biomarkers; Candidate Therapeutics; Coronavirus Infection; Host Response

$255,970

Sex as a Biological Variable Supplement - Host Response Mediators in Coronavirus (COVID-19) Infection

Co-investigatorCIHR2020Op Grant: Sex as a Biological Variable Supplement: COVID-19 Rapid Research FO

Principal investigators: Russell, James A

Keywords: Arbs; Biomarkers; Candidate Therapeutics; Coronavirus Infection; Host Response

$49,932

Canadian Treatments for COVID-19: SOLIDARITY

Nominated PICIHR2020Operating Grant: WHO Solidarity Trial Scale-Up COVID-19 Funding Opportunity

Principal investigators: Murthy, Srinivas; Fowler, Robert A

Keywords: Clinical Characterization; Knowledge Translation; Randomized Clinical Trial; Stakeholder Perspectives

$3,550,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Srinivas Murthy

Research

Latest papers

Latest funding

Greening critical care by harnessing the planetary impact of medications: What fellows need to know.

Residual Myths in Feeding Critically Ill Children.

Enteral nutrition usage in critically ill children: A descriptive cohort study.

The challenge of recruitment in clinical trials in Canada: an analysis of trial registry data.

Timing, Translation, and Preparedness: Lessons Learned From COVID-19 Anticoagulation in Noncritically Ill Hospitalized Patients.

Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP).

Which issues should be addressed in future trials regarding the use of corticosteroids in community acquired pneumonia? A survey of REMAP-CAP investigators.

Intermediate dose heparin thromboprophylaxis among critically ill patients with COVID-19: a randomized clinical trial.

Lessons learned and recommendations from the Canadian adaptive platform trial of treatments for COVID in community settings (CanTreatCOVID).

Time to extracorporeal cardiopulmonary resuscitation flow and outcomes in paediatric in-hospital cardiac arrest: a 12-year single-centre study.

Frequent collaborators

Francois Lamontagne

Ryan Zarychanski

Bram Rochwerg

Karen Burns

Robert Fowler

Jennifer Tsang

John Marshall

Michelle Kho

Gordon Guyatt

Gloria Vazquez-Grande

Deborah Cook

Anand Kumar

Kusum Menon

Nick Daneman

Ruxandra Pinto

Patricia Fontela

Patricia Fontela

Sangeeta Mehta

Peter Daley

Marc Carrier

Srinivas Murthy

Arnav Agarwal

Dena Zeraatkar

Ryan Zarychanski

Srinivas Murthy

Murdoch Leeies

Ryan Zarychanski

Srinivas Murthy

Rachel Couban

Emilie Belley-Cote

David Maslove

Emily Rimmer

Aleksandra Leligdowicz

Christina Maratta

Karen Tran

Francois Lamontagne

Philippe Jouvet

Yoav Keynan

Nicholas Mitsakakis

Marc Carrier